Natural history of congenital generalized lipodystrophy: A nationwide study from Turkey

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 7, 2016, Pages 2759-2767

  Akinci, Baris ^a   Onay, Huseyin ^b   Demir, Tevfik ^a   Ozen, Samim ^b   Kayserili, Hulya ^c,d   Akinci, Gulcin ^e   Nur, Banu ^f   Tuysuz, Beyhan ^g   Ozbek, Mehmet Nuri ^h   Gungor, Adem ⁱ   Simsir, Ilgin Yildirim ^b   Altay, Canan ^a   Demir, Leyla ^j   Simsek, Enver ^k   Atmaca, Murat ^l   Topaloglu, Haluk ^m   Bilen, Habib ⁱ   Atmaca, Hulusi ⁿ   Atik, Tahir ^b   Cavdar, Umit ^a   Altunoglu, Umut ^c   Aslanger, Ayca ^d   Mihci, Ercan ^f   Secil, Mustafa ^a   Saygili, Fusun ^j   Comlekci, Abdurrahman ^a   Garg, Abhimanyu ^o   more..

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d KOÇ UNIVERSITY   (Turkey)

^e DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

^f AKDENIZ UNIVERSITY   (Turkey)

^g ISTANBUL UNIVERSITY CERRAHPASA   (Turkey)

^h Diyarbakir Children Hospital   (Turkey)

ⁱ ATATÜRK UNIVERSITY   (Turkey)

^j ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^k ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^l YUZUNCU YIL UNIVERSITY   (Turkey)

^m HACETTEPE UNIVERSITY   (Turkey)

ⁿ ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^o UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADIPONECTIN; CYTOSINE; GLUCOSE; GUANINE; LIVER ENZYME; THYMINE; 2-ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; ACYLTRANSFERASE; BSCL2 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT;

ACANTHOSIS NIGRICANS; ACROMEGALY; ACUTE PANCREATITIS; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGPAT2 GENE; AMPUTATION; ARTICLE; BONE CYST; BSCL2 GENE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLICATION; CONGENITAL GENERALIZED LIPODYSTROPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DIET RESTRICTION; END STAGE RENAL DISEASE; FATTY LIVER; FEMALE; FOLLOW UP; FOOT SOLE; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAND PALM; HEART ATRIUM FLUTTER; HETEROZYGOTE; HISTORY OF MEDICINE; HOMOZYGOTE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN RESISTANCE; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; MALE; MENTAL DEFICIENCY; METABOLIC DISORDER; MICROALBUMINURIA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT; OVARY POLYCYSTIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; PTRF GENE; RETINOPATHY; SCALP; SCHOOL CHILD; SEIZURE; SPLEEN ARTERY ANEURYSM; SUBCLINICAL HYPOTHYROIDISM; TOXIC GOITER; TURKEY (REPUBLIC); YOUNG ADULT; CASE CONTROL STUDY; DISEASE COURSE; DNA MUTATIONAL ANALYSIS; GENETICS; LIPODYSTROPHY, CONGENITAL GENERALIZED; PATHOLOGY; PROGNOSIS; TURKEY;

ACYLTRANSFERASES; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GTP-BINDING PROTEIN GAMMA SUBUNITS; HUMANS; INFANT; INSULIN RESISTANCE; LIPODYSTROPHY, CONGENITAL GENERALIZED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; TURKEY; YOUNG ADULT;

EID: 84978382674     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1005     Document Type: Article

References (37)

1. Garg A. Lipodystrophies. Am J Med. 2000;108:143-152.
2. Agarwal AK, Arioglu E, De Almeida S, et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 2002;31:21-23.
3. Takeuchi K, Reue K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am J Physiol Endocrinol Metab. 2009;296:E1195-E1209.
4. Magre J, Delepine M, Khallouf E, et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28:365-370.
5. Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genomics Hum Genet. 2006;7:175-199.
6. Cohen AW, Razani B, Schubert W, et al. Role of caveolin-1 in the modulationoflipolysis and lipid droplet formation. Diabetes. 2004; 53:1261-1270.
7. Garg A, Agarwal AK. Caveolin-1: a new locus for human lipodys-trophy. J Clin Endocrinol Metab. 2008;93:1183-1185.
8. Kim CA, Delepine M, Boutet E, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital li-podystrophy. J Clin Endocrinol Metab. 2008;93:1129-1134.
9. Hayashi YK, Matsuda C, Ogawa M, et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009;119: 2623-2633.
10. Shastry S, Delgado MR, Dirik E, Turkmen M, Agarwal AK, Garg A. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Am J Med Genet A. 2010;152A:2245-2253.
11. Chou K, Perry CM. Metreleptin: first global approval.Drugs. 2013; 73:989-997.
12. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570-578.
13. Javor ED, Moran SA, Young JR, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin En-docrinol Metab. 2004;89:3199-3207.
14. Patni N, Garg A. Congenital generalized lipodystrophies-new insights into metabolic dysfunction. Nat Rev Endocrinol. 2015;11: 522-534.
15. Miranda DM, Wajchenberg BL, Calsolari MR, et al. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berar-dinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol (Oxf). 2009;71:512-517.
16. Haghighi A, Razzaghy-Azar M, Talea A, Sadeghian M, Ellard S. Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodys-trophy type 1. Eur J Med Genet. 2012;55:620-624.
17. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7: 248-249.
18. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073-1081.
19. Schwarz JM, Cooper DN, Schuelke M, Seelow D. Mutation Taster 2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361-362.
20. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.
21. 2014 Standards of medical care in diabetes. Diabetes Care. 2014; 37(Suppl 1):S14-S80.
22. 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285:2486-2497.
23. 2011 Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-S256.
24. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Am Fam Physician. 1992;45:2127-2136.
25. Magre J, Delepine M, Van Maldergem L, et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes. 2003; 52:1573-1578.
26. van der Pol RJ, Benninga MA, Magre J, et al. Berardinelli-Seip syndrome and achalasia: a shared pathomechanism? Eur J Pediatr. 2015;174:975-980.
27. Haghighi A, Kavehmanesh Z, Salehzadeh F, et al. 2015 Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum. Clin Genet. In press.
28. Garg A. Clinical review: lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313-3325.
29. Simha V, Garg A. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy causedbymu-tations in the AGPAT2 or seipin genes. J Clin Endocrinol Metab. 2003;88:5433-5437.
30. Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocri-nol Metab. 2003;88:4840-4847.
31. Van Maldergem L, Magre J, Khallouf TE, et al. Genotype-pheno-type relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet. 2002;39:722-733.
32. Antuna-Puente B, Boutet E, Vigouroux C, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyl-transferase-2 deficiency. J Clin Endocrinol Metab. 2010;95:1463-1468.
33. Casali RE, Resnick J, Goetz F, Simmons RL, Najarian JS, Kjellstrand C. Renal transplantation in a patient with lipoatrophic diabetes. A case report. Transplantation. 1978;26:174-177.
34. McNally M, Mannon RB, Javor ED, et al. Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report. Am J Transplant. 2004;4:447-449.
35. Rajab A, Straub V, McCann LJ, et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipo-dystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet. 2010;6:e1000874.
36. Murakami N, Hayashi YK, Oto Y, et al. Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood. Neuromuscul Disord. 2013;23:441-444.
37. Gurakan F, Kocak N, Yuce A. Congenital generalized lipodystro-phy: Berardinelli syndrome. Report of two siblings. Turk J Pediatr. 1995;37:241-246.